UBS Group’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-250,249
| Closed | -$12.5M | – | 11117 |
|
|
2025
Q4 | $12.5M | Sell |
250,249
-598,092
| -71% | -$28.8M | ﹤0.01% | 3055 |
|
|
2025
Q3 | $41.6M | Buy |
848,341
+387,360
| +84% | +$19.8M | 0.01% | 1816 |
|
|
2025
Q2 | $23.9M | Sell |
460,981
-910,056
| -66% | -$41.8M | ﹤0.01% | 2188 |
|
|
2025
Q1 | $64.1M | Buy |
1,371,037
+491,705
| +56% | +$25.4M | 0.01% | 1255 |
|
|
2024
Q4 | $45M | Buy |
879,332
+704,747
| +404% | +$36.5M | 0.01% | 1557 |
|
|
2024
Q3 | $7.76M | Buy |
174,585
+34,480
| +25% | +$1.51M | ﹤0.01% | 2623 |
|
|
2024
Q2 | $5.63M | Buy |
140,105
+72,994
| +109% | +$2.77M | ﹤0.01% | 2758 |
|
|
2024
Q1 | $2.69M | Buy |
67,111
+60,645
| +938% | +$2.28M | ﹤0.01% | 3639 |
|
|
2023
Q4 | $243K | Sell |
6,466
-74,112
| -92% | -$2.27M | ﹤0.01% | 5640 |
|
|
2023
Q3 | $2.24M | Buy |
80,578
+74,055
| +1,135% | +$2.32M | ﹤0.01% | 3335 |
|
|
2023
Q2 | $197K | Sell |
6,523
-44,701
| -87% | -$1.31M | ﹤0.01% | 5486 |
|
|
2023
Q1 | $1.58M | Sell |
51,224
-18,444
| -26% | -$702K | ﹤0.01% | 3678 |
|
|
2022
Q4 | $2.62M | Buy |
69,668
+20,196
| +41% | +$802K | ﹤0.01% | 3122 |
|
|
2022
Q3 | $1.86M | Sell |
49,472
-4,334
| -8% | -$172K | ﹤0.01% | 3223 |
|
|
2022
Q2 | $1.94M | Sell |
53,806
-27,383
| -34% | -$1.13M | ﹤0.01% | 3177 |
|
|
2022
Q1 | $3.98M | Sell |
81,189
-86,028
| -51% | -$4.36M | ﹤0.01% | 2765 |
|
|
2021
Q4 | $8.01M | Sell |
167,217
-24,658
| -13% | -$1.17M | ﹤0.01% | 2352 |
|
|
2021
Q3 | $8.42M | Sell |
191,875
-149,577
| -44% | -$6.32M | ﹤0.01% | 2183 |
|
|
2021
Q2 | $15M | Buy |
341,452
+126,826
| +59% | +$5.96M | ﹤0.01% | 1712 |
|
|
2021
Q1 | $9.82M | Sell |
214,626
-48,190
| -18% | -$2.02M | ﹤0.01% | 1959 |
|
|
2020
Q4 | $8.51M | Sell |
262,816
-125,444
| -32% | -$3.63M | ﹤0.01% | 1977 |
|
|
2020
Q3 | $8.22M | Buy |
388,260
+217,764
| +128% | +$4.54M | ﹤0.01% | 1787 |
|
|
2020
Q2 | $3.5M | Buy |
170,496
+80,551
| +90% | +$1.56M | ﹤0.01% | 2359 |
|
|
2020
Q1 | $1.58M | Sell |
89,945
-60,550
| -40% | -$1.87M | ﹤0.01% | 2981 |
|
|
2019
Q4 | $5.9M | Sell |
150,495
-20,238
| -12% | -$744K | ﹤0.01% | 2458 |
|
|
2019
Q3 | $6.11M | Buy |
170,733
+20,193
| +13% | +$724K | ﹤0.01% | 2193 |
|
|
2019
Q2 | $5.27M | Sell |
150,540
-55,832
| -27% | -$1.94M | ﹤0.01% | 2283 |
|
|
2019
Q1 | $7.09M | Buy |
206,372
+128,590
| +165% | +$4.72M | ﹤0.01% | 1934 |
|
|
2018
Q4 | $2.49M | Sell |
77,782
-36,530
| -32% | -$1.38M | ﹤0.01% | 2826 |
|
|
2018
Q3 | $5.23M | Buy |
114,312
+19,233
| +20% | +$968K | ﹤0.01% | 2308 |
|
|
2018
Q2 | $5.02M | Sell |
95,079
-39,853
| -30% | -$2.12M | ﹤0.01% | 2337 |
|
|
2018
Q1 | $6.74M | Buy |
134,932
+6,225
| +5% | +$314K | ﹤0.01% | 2035 |
|
|
2017
Q4 | $6.17M | Buy |
128,707
+38,786
| +43% | +$1.84M | ﹤0.01% | 2147 |
|
|
2017
Q3 | $4.14M | Buy |
89,921
+293
| +0.3% | +$12.7K | ﹤0.01% | 2395 |
|
|
2017
Q2 | $3.96M | Sell |
89,628
-3,122
| -3% | -$131K | ﹤0.01% | 2361 |
|
|
2017
Q1 | $3.81M | Sell |
92,750
-7,565
| -8% | -$316K | ﹤0.01% | 2333 |
|
|
2016
Q4 | $4.12M | Sell |
100,315
-8,516
| -8% | -$313K | ﹤0.01% | 2274 |
|
|
2016
Q3 | $3.54M | Sell |
108,831
-36,990
| -25% | -$1.16M | ﹤0.01% | 2343 |
|
|
2016
Q2 | $4.23M | Buy |
145,821
+21,186
| +17% | +$643K | ﹤0.01% | 2090 |
|
|
2016
Q1 | $3.6M | Buy |
124,635
+16,911
| +16% | +$485K | ﹤0.01% | 2151 |
|
|
2015
Q4 | $3.49M | Buy |
107,724
+7,231
| +7% | +$231K | ﹤0.01% | 2272 |
|
|
2015
Q3 | $2.98M | Sell |
100,493
-111,672
| -53% | -$3.42M | ﹤0.01% | 2390 |
|
|
2015
Q2 | $6.54M | Sell |
212,165
-21,790
| -9% | -$630K | ﹤0.01% | 1825 |
|
|
2015
Q1 | $6.55M | Buy |
233,955
+141,584
| +153% | +$3.84M | ﹤0.01% | 1840 |
|
|
2014
Q4 | $2.5M | Buy |
+92,371
| New | +$2.33M | ﹤0.01% | 2684 |
|
Other funds holding SNV
UBS Group's SNV Position: Q1 2026 in Review
UBS Group sold out of Synovus (SNV) in Q1 2026, closing a stake of 250,249 shares — an estimated $12.5M sold.
UBS Group first reported a position in SNV in Q4 2014 and held it in 45 quarters. The position peaked at $64.1M in Q1 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.
- UBS Group reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 250,249 Synovus shares in Q1 2026, an estimated $12.5M.
- UBS Group first reported a position in Synovus in Q4 2014 and held it in 45 quarters.
- UBS Group's Synovus position peaked at $64.1M in Q1 2025.
- 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.